Latest Atrium Innovations (ATBIF) Headlines
Global Vitamins Market 2014-2018: Cosmeceutical Industry Expected to Grow at a CAGR of Over 7% during Forecast Period
M2 - Mon Feb 17, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/cp6qhr/global_vitamins) has announced the addition of the "Global Vitamins Market 2014-2018" report to their offering. The analysts forecast the Global Vitamins market to grow at a CAGR of 6.15 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased use in functional food and beverages. The Global Vitamins market has also been witnessing increasing demand from the Cosmeceuticals industry. However, differences in consumer preferences could pose a challenge to the growth of this market. Key vendors dominating this space are Adisseo France S.A.S, Archer Daniels Midland Co., BASF SE, and Royal DSM N.V. Other vendors mentioned in the report are 7 Day Health Corp., ABH Nature's Products Inc., AIE Pharmaceuticals Inc., Aland (Jiangsu) Nutraceutical Co. Ltd., Atlantic Essential Products Inc., Atrium Innovations Inc., Bactolac Pharmaceutical Inc., Bluebonnet Nutrition Corp., CSPC Pharmaceutical Group Ltd., Danisco A/S, Glanbia Nutritionals Deutschland GmbH, Kirkman Group Inc., Lonza Group Ltd., Nattopharma ASA, Nature's Plus, NBTY Inc., North China Pharmaceutical Corp., Nulab Inc., Nutricap Labs, Nutrilite, Nutrilo GmbH, ParkAcre Enterprises Ltd., Pfizer Inc., Pharmavite LLC, Private Label Nutraceuticals LLC, Sanofi SA, Schiff Nutrition International Inc., Thorne Research Inc., Vertellus Specialties Inc., and Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd. Commenting on the report, an analyst from the team said: Cosmeceuticals are cosmetics with pharmacological benefits. The Global Vitamins market is witnessing an increasing demand from the Cosmeceutical industry, which is expected to grow at a CAGR of over 7 percent during the forecast period. The demand for vitamins is particularly strong from the Skin Care segment of the Cosmeceutical industry. Some of the vitamins that are commonly used by this segment are vitamin B3, vitamin K, vitamin E, and vitamin A and its derivatives, such as retinol, retinaldehyde, oxoretinoids, and retinyl esters. Also, cosmeceuticals with vitamins are increasingly used as therapeutic adjuncts. According to the report, many drivers are contributing to the growth of the Global Vitamins market, the most important of which is the increased use of vitamins in functional food and beverages. While vitamins are largely consumed as dietary supplements, their usage in functional food and beverages has increased significantly, thereby contributing to the growth of the market. For more information visit http://www.researchandmarkets.com/research/cp...l_vitamins About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Atrium Innovations Announces Completion of Acquisition by the Permira Funds
CNW Group - Thu Feb 13, 9:36AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today the successful completion of the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all of the outstanding common shares of Atrium ("Atrium Shares") by corporations backed by the Permira funds ("Permira") and the acquisition by the Corporation of all of its outstanding 5.75% convertible unsecured subordinated debentures ("Atrium Debentures").
Atrium Innovations Inc. Receives Investment Canada Act Approval for the Arrangement with the Permira Funds
CNW Group - Mon Feb 10, 6:30AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, is pleased to announce that pursuant to the terms of the Investment Canada Act, the Minister of Industry (the "Minister") has approved the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all of the outstanding common shares of Atrium by corporations backed by the Permira funds and the acquisition by the Corporation of all of its outstanding convertible debentures. The Minister reviewed the Arrangement pursuant to the Investment Canada Act, and determined that it is of net benefit to Canada. In addition, the Corporation has received clearance from the Ukrainian competition authorities with respect to the Arrangement.
School Specialty Enhances Operational Team With the Appointment of Two Industry Veterans
GlobeNewswire - Thu Feb 06, 9:00AM CST
School Specialty Inc. (OTCQB:SCOO) ("SSI" or "the Company"), a leading distributor of supplies, furniture and both supplemental and curriculum products to the education marketplace, today announced two new leadership appointments as the Company continues to build out its operational team to enhance customer satisfaction.
Atrium Innovations Inc. Receives Final Court Approval of Arrangement with the Permira Funds
CNW Group - Mon Jan 27, 10:00AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that the Superior Court of Québec (Commercial Division) issued a final order approving the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all of the outstanding common shares of Atrium for cash consideration of $24.00 per common share by corporations backed by the Permira funds and the acquisition by the Corporation of all of its outstanding convertible debentures.
Atrium Innovations' Securityholders Approve Arrangement with the Permira Funds
CNW Group - Tue Jan 21, 10:32AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that its shareholders and convertible debentureholders (together the "Securityholders") have approved the resolution authorizing the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all the outstanding Atrium shares for cash consideration of $24.00 per common share by corporations backed by the Permira funds and the acquisition by the Corporation of all of its outstanding convertible debentures. Pursuant to the Arrangement, Atrium's senior management will be rolling over up to approximately $8 million of equity investment in the Corporation.
Atrium Innovations Announces Expiry of Go Shop Period
CNW Group - Tue Jan 14, 6:30AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that, in accordance with the terms of the arrangement agreement entered into on November 29, 2013 regarding the plan of arrangement (the "Arrangement") providing for the previously announced acquisition of Atrium by corporations backed by the Permira funds, the 45-day go shop period during which Atrium was permitted to solicit superior proposals expired on January 13, 2014 at 11:59 p.m. (Montréal time).
Atrium Innovations Announces Two Leading Independent Proxy Advisory Firms Recommend Voting in Favour of the Acquisition by the Permira Funds
CNW Group - Tue Jan 07, 6:30AM CST
Special Meeting of the shareholders and convertible debentureholders of Atrium to be held on January 21, 2014 to approve the announced Plan of Arrangement
Atrium Innovations Files Management Information Circular for Special Meeting of Shareholders and Convertible Debentureholders
CNW Group - Mon Dec 23, 6:00AM CST
Special Meeting to be held on January 21, 2014 to approve the announced Plan of Arrangement
IIROC Trade Resumption - ATB
CNW Group - Fri Nov 29, 8:20AM CST
Trading resumes in:
IIROC Trading Halt - ATB
CNW Group - Fri Nov 29, 8:18AM CST
The following issues have been halted by IIROC:
IIROC Trade Resumption - Atrium Innovations Inc.
Newsfile Corp - Fri Nov 29, 8:17AM CST
Trading resumes in:
IIROC Trade Halt - Atrium Innovations Inc.
Newsfile Corp - Fri Nov 29, 8:14AM CST
The following issues have been halted by IIROC:
Atrium Innovations Inc. to be acquired by the Permira funds and a group of Québec investors
CNW Group - Fri Nov 29, 7:54AM CST
All dollar amounts in C$ unless otherwise noted
/R E P E A T -- Media Advisory - Atrium Innovations to Host Analyst/Investor Meeting in Montreal on November 20/
CNW Group - Wed Nov 13, 6:00AM CST
Atrium Innovations ("the Company") will be hosting an analyst/institutional investor lunch meeting on November 20, 2013 in Montreal. During this meeting, several key executives of the Company will make short presentations followed by an informal session for questions.
Atrium Innovations Announces the Renewal of its Normal Course Issuer Bid
CNW Group - Mon Nov 11, 3:52PM CST
Atrium Innovations Inc. (TSX: ATB) ("Atrium" or the "Company"), a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products, announced today that it has filed with the Toronto Stock Exchange ("TSX"), and the TSX has accepted, a Notice of Intention to make a Normal Course Issuer Bid. Under its normal course issuer bid, Atrium intends to purchase up to 1,095,474 of its common shares, representing approximately 3.5% of the 31,299,261 common shares issued and outstanding as of October 31, 2013. The average daily trading volume for the 6-month period preceding October 31, 2013 represents 36,203 common shares. In accordance with the TSX requirements, a maximum daily purchase of the greater of 25% of this average or 1,000 shares may be made, which represents a total of 9,050 common shares.
Atrium Innovations Announces 2013 Third Quarter Financial Results
CNW Group - Mon Nov 11, 3:51PM CST
Another Strong Performance - Q3 Solid Organic Growth
Media advisory - Atrium Innovations to Hold 2013 Third Quarter Financial Results Conference Call and Webcast on November 12, 2013
CNW Group - Mon Nov 04, 9:23AM CST
Atrium Innovations Inc. (TSX: ATB) ("Atrium" or "the Company") will hold its quarterly conference call and webcast at 8:00 a.m. Eastern time on November 12, 2013. The call will follow the press release of Atrium's 2013 third quarter results, which will be issued the day before, after market close.
Atrium Innovations Announces Resignation of Director
CNW Group - Mon Oct 21, 3:33PM CDT
Atrium Innovations Inc. (TSX: ATB) ("Atrium" or the "Company"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, today announced that Mr. Alain Bouchard, a director of Atrium, has informed the Company of his decision to resign from the board, effective immediately.
Global Vitamins Market 2014-2018: Cosmeceutical Industry Expected to Grow at a CAGR of Over 7% during Forecast Period
M2 - Mon Feb 17, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/cp6qhr/global_vitamins) has announced the addition of the "Global Vitamins Market 2014-2018" report to their offering. The analysts forecast the Global Vitamins market to grow at a CAGR of 6.15 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased use in functional food and beverages. The Global Vitamins market has also been witnessing increasing demand from the Cosmeceuticals industry. However, differences in consumer preferences could pose a challenge to the growth of this market. Key vendors dominating this space are Adisseo France S.A.S, Archer Daniels Midland Co., BASF SE, and Royal DSM N.V. Other vendors mentioned in the report are 7 Day Health Corp., ABH Nature's Products Inc., AIE Pharmaceuticals Inc., Aland (Jiangsu) Nutraceutical Co. Ltd., Atlantic Essential Products Inc., Atrium Innovations Inc., Bactolac Pharmaceutical Inc., Bluebonnet Nutrition Corp., CSPC Pharmaceutical Group Ltd., Danisco A/S, Glanbia Nutritionals Deutschland GmbH, Kirkman Group Inc., Lonza Group Ltd., Nattopharma ASA, Nature's Plus, NBTY Inc., North China Pharmaceutical Corp., Nulab Inc., Nutricap Labs, Nutrilite, Nutrilo GmbH, ParkAcre Enterprises Ltd., Pfizer Inc., Pharmavite LLC, Private Label Nutraceuticals LLC, Sanofi SA, Schiff Nutrition International Inc., Thorne Research Inc., Vertellus Specialties Inc., and Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd. Commenting on the report, an analyst from the team said: Cosmeceuticals are cosmetics with pharmacological benefits. The Global Vitamins market is witnessing an increasing demand from the Cosmeceutical industry, which is expected to grow at a CAGR of over 7 percent during the forecast period. The demand for vitamins is particularly strong from the Skin Care segment of the Cosmeceutical industry. Some of the vitamins that are commonly used by this segment are vitamin B3, vitamin K, vitamin E, and vitamin A and its derivatives, such as retinol, retinaldehyde, oxoretinoids, and retinyl esters. Also, cosmeceuticals with vitamins are increasingly used as therapeutic adjuncts. According to the report, many drivers are contributing to the growth of the Global Vitamins market, the most important of which is the increased use of vitamins in functional food and beverages. While vitamins are largely consumed as dietary supplements, their usage in functional food and beverages has increased significantly, thereby contributing to the growth of the market. For more information visit http://www.researchandmarkets.com/research/cp...l_vitamins About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Atrium Innovations Announces Completion of Acquisition by the Permira Funds
CNW Group - Thu Feb 13, 9:36AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today the successful completion of the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all of the outstanding common shares of Atrium ("Atrium Shares") by corporations backed by the Permira funds ("Permira") and the acquisition by the Corporation of all of its outstanding 5.75% convertible unsecured subordinated debentures ("Atrium Debentures").
Atrium Innovations Inc. Receives Investment Canada Act Approval for the Arrangement with the Permira Funds
CNW Group - Mon Feb 10, 6:30AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, is pleased to announce that pursuant to the terms of the Investment Canada Act, the Minister of Industry (the "Minister") has approved the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all of the outstanding common shares of Atrium by corporations backed by the Permira funds and the acquisition by the Corporation of all of its outstanding convertible debentures. The Minister reviewed the Arrangement pursuant to the Investment Canada Act, and determined that it is of net benefit to Canada. In addition, the Corporation has received clearance from the Ukrainian competition authorities with respect to the Arrangement.
School Specialty Enhances Operational Team With the Appointment of Two Industry Veterans
GlobeNewswire - Thu Feb 06, 9:00AM CST
School Specialty Inc. (OTCQB:SCOO) ("SSI" or "the Company"), a leading distributor of supplies, furniture and both supplemental and curriculum products to the education marketplace, today announced two new leadership appointments as the Company continues to build out its operational team to enhance customer satisfaction.
Atrium Innovations Inc. Receives Final Court Approval of Arrangement with the Permira Funds
CNW Group - Mon Jan 27, 10:00AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that the Superior Court of Québec (Commercial Division) issued a final order approving the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all of the outstanding common shares of Atrium for cash consideration of $24.00 per common share by corporations backed by the Permira funds and the acquisition by the Corporation of all of its outstanding convertible debentures.
Atrium Innovations' Securityholders Approve Arrangement with the Permira Funds
CNW Group - Tue Jan 21, 10:32AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that its shareholders and convertible debentureholders (together the "Securityholders") have approved the resolution authorizing the previously announced plan of arrangement (the "Arrangement") providing for the acquisition of all the outstanding Atrium shares for cash consideration of $24.00 per common share by corporations backed by the Permira funds and the acquisition by the Corporation of all of its outstanding convertible debentures. Pursuant to the Arrangement, Atrium's senior management will be rolling over up to approximately $8 million of equity investment in the Corporation.
Atrium Innovations Announces Expiry of Go Shop Period
CNW Group - Tue Jan 14, 6:30AM CST
Atrium Innovations Inc. (TSX:ATB & ATB.DB) ("Atrium" or the "Corporation"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that, in accordance with the terms of the arrangement agreement entered into on November 29, 2013 regarding the plan of arrangement (the "Arrangement") providing for the previously announced acquisition of Atrium by corporations backed by the Permira funds, the 45-day go shop period during which Atrium was permitted to solicit superior proposals expired on January 13, 2014 at 11:59 p.m. (Montréal time).
Atrium Innovations Announces Two Leading Independent Proxy Advisory Firms Recommend Voting in Favour of the Acquisition by the Permira Funds
CNW Group - Tue Jan 07, 6:30AM CST
Special Meeting of the shareholders and convertible debentureholders of Atrium to be held on January 21, 2014 to approve the announced Plan of Arrangement
Atrium Innovations Files Management Information Circular for Special Meeting of Shareholders and Convertible Debentureholders
CNW Group - Mon Dec 23, 6:00AM CST
Special Meeting to be held on January 21, 2014 to approve the announced Plan of Arrangement
IIROC Trade Resumption - ATB
CNW Group - Fri Nov 29, 8:20AM CST
Trading resumes in:
IIROC Trading Halt - ATB
CNW Group - Fri Nov 29, 8:18AM CST
The following issues have been halted by IIROC:
IIROC Trade Resumption - Atrium Innovations Inc.
Newsfile Corp - Fri Nov 29, 8:17AM CST
Trading resumes in:
IIROC Trade Halt - Atrium Innovations Inc.
Newsfile Corp - Fri Nov 29, 8:14AM CST
The following issues have been halted by IIROC:
Atrium Innovations Inc. to be acquired by the Permira funds and a group of Québec investors
CNW Group - Fri Nov 29, 7:54AM CST
All dollar amounts in C$ unless otherwise noted
/R E P E A T -- Media Advisory - Atrium Innovations to Host Analyst/Investor Meeting in Montreal on November 20/
CNW Group - Wed Nov 13, 6:00AM CST
Atrium Innovations ("the Company") will be hosting an analyst/institutional investor lunch meeting on November 20, 2013 in Montreal. During this meeting, several key executives of the Company will make short presentations followed by an informal session for questions.
Atrium Innovations Announces the Renewal of its Normal Course Issuer Bid
CNW Group - Mon Nov 11, 3:52PM CST
Atrium Innovations Inc. (TSX: ATB) ("Atrium" or the "Company"), a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products, announced today that it has filed with the Toronto Stock Exchange ("TSX"), and the TSX has accepted, a Notice of Intention to make a Normal Course Issuer Bid. Under its normal course issuer bid, Atrium intends to purchase up to 1,095,474 of its common shares, representing approximately 3.5% of the 31,299,261 common shares issued and outstanding as of October 31, 2013. The average daily trading volume for the 6-month period preceding October 31, 2013 represents 36,203 common shares. In accordance with the TSX requirements, a maximum daily purchase of the greater of 25% of this average or 1,000 shares may be made, which represents a total of 9,050 common shares.
Atrium Innovations Announces 2013 Third Quarter Financial Results
CNW Group - Mon Nov 11, 3:51PM CST
Another Strong Performance - Q3 Solid Organic Growth
Media advisory - Atrium Innovations to Hold 2013 Third Quarter Financial Results Conference Call and Webcast on November 12, 2013
CNW Group - Mon Nov 04, 9:23AM CST
Atrium Innovations Inc. (TSX: ATB) ("Atrium" or "the Company") will hold its quarterly conference call and webcast at 8:00 a.m. Eastern time on November 12, 2013. The call will follow the press release of Atrium's 2013 third quarter results, which will be issued the day before, after market close.
Atrium Innovations Announces Resignation of Director
CNW Group - Mon Oct 21, 3:33PM CDT
Atrium Innovations Inc. (TSX: ATB) ("Atrium" or the "Company"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, today announced that Mr. Alain Bouchard, a director of Atrium, has informed the Company of his decision to resign from the board, effective immediately.
